(PharmaNewsWire.Com, June 17, 2019 ) The colposcopy market is geographically segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to register the highest growth due to the increasing burden of cervical cancer and growth in the demand for cervical cancer screening in the region.
Market leaders and emerging players are increasingly focusing on the market segments mentioned above to increase their revenues and are also looking to expand their reach to emerging economies
The colposcopy market is projected to reach USD 740.1 Million by 2023 from USD 532.6 Million in 2018, at a CAGR of 6.8% from 2018 to 2023.
Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market.
Target Audience for this Report: -Manufacturers and vendors of colposcopy -Research associations related to cervical cancer -Various research and consulting firms -Distributors of colposcopy products -Contract manufacturers of colposcopy products -Healthcare institutions -Research institutes
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: